Talimogene laherparepvec
Generic name: talimogene laherparepvec [ tal-IM-oh-jeen-la-HER-pa-REP-vek ]
Brand name: Imlygic
Dosage form: injectable suspension (1 mpfu/mL; 100 mpfu/mL)
Drug class:Miscellaneous antineoplastics
What is talimogene laherparepvec?
Talimogene laherparepvec is a cancer medicine that affects the actions of the body's immune system, helping the body produce an "antitumor" response. Talimogene laherparepvec is a genetically modified weak form of type 1 herpes simplex virus (the virus that causes common cold sores).
Talimogene laherparepvec is used to treat a type of cancer called melanoma when it is on the skin or in the lymph glands.
Talimogene laherparepvec may also be used for purposes not listed in this medication guide.
Warnings
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
Before taking this medicine
Accidental exposure to the virus in talimogene laherparepvec may cause you to develop symptoms of herpes virus infection. However, not treating melanoma can allow the cancer to progress and spread to other parts of the body. Melanoma is difficult to treat after it progresses, and this type of cancer can be fatal. Talk to your doctor about the risks and benefits of using talimogene laherparepvec.
You should not be treated with talimogene laherparepvec if you are allergic to it, or if:
you have a weak immune system (caused by disease or by using certain medicine); or
you are pregnant.
Tell your doctor if you have ever had:
cold sores or genital herpes;
blood cancer (leukemia);
bone marrow cancer (myeloma);
HIV or AIDS; or
an autoimmune disorder such as rheumatoid arthritis, lupus, or psoriasis.
Tell your doctor if anyone in your household is pregnant or has a weak immune system.
Use effective birth control to prevent pregnancy, and tell your doctor if you become pregnant. If you develop symptoms of herpes virus infection while using talimogene laherparepvec, the virus could be passed to your baby during childbirth.
It may not be safe to breastfeed while using talimogene laherparepvec. Ask your doctor about any ris...
